Article Text

Download PDFPDF
Organic neuropsychiatry: a treatable cause of suicidal behaviour

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors All authors have contributed to the patient report and the writing of the manuscript. LJ, SRI and AV produced figure 1. SRI, AV and RJB produced figure 2.

  • Funding SRI was supported by the National Institute for Health Research (NIHR), Department of Health, UK. This work has been supported by the NIHR-funded Oxford Biomedical Research Centre. AV and the Department of Clinical Neurology in Oxford receive royalties and payments for antibody assays and AV is the named inventor on patent application WO/2010/046716 entitled ‘Neurological Autoimmune Disorders’. The patent has been licensed to Euroimmun AG for the development of assys for the LGI1 and other VGKC-complex antibodies. SRI is a co-inventor and may also receive future royalties.

  • Competing interests None.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed. This paper was reviewed by Jonathan Schott, London, UK.

Other content recommended for you